CN EN
CN EN

Please enter the information you want to find

Hot key words：
Hyaluronidase xxx
Acting on the needs of patients Acting on the needs of patients

Responding to urgent patient needs
Innovating for diverse health challenges

Explore Bao Pharma’s pipeline
A subcutaneous drug delivery platform offers a revolutionary upgrade opportunity for conventional intravenous medications. A subcutaneous drug delivery platform offers a revolutionary upgrade opportunity for conventional intravenous medications.

Hysorptase®
Recombinant human hyaluronidase

A subcutaneous drug delivery platform offers a revolutionary upgrade opportunity for conventional intravenous medications.

Offering patients a safer, time-saving, and more comfortable medication experience

learn about our platform
Ricefidase (KJ103)Recombinant IgG Cleaving Enzyme Ricefidase (KJ103)Recombinant IgG Cleaving Enzyme

Ricefidase (KJ103)
Recombinant IgG Cleaving Enzyme

Committed to meeting the clinical needs of patients with acute and severe autoimmune diseases, organ transplant recipients, and those requiring gene therapy, across various disease areas
Discover more

Science and innovation

Recombinant IgG Cleaving Enzyme

Ricefidase

Recombinant IgG Cleaving Enzyme

Recombinant IgG Cleaving Enzyme
Recombinant Human Hyaluronidase

Hysorptase®

Recombinant Human Hyaluronidase

Recombinant Human Hyaluronidase
Improving the treatment experience for patients’ health and well-being

Improving the treatment experience
for patients’ health and well-being

Providing innovative therapies for patients

fawiconimg1.png

Improving quality of life for patients

fawiconimg2.png

Providing support and education for patients

fawiconimg3.png

Promoting patient involvement in medical advancements

fawiconimg4.png